CALIXAR and HÖLZEL finalize a distribution agreement

CALIXAR is proud to announce the beginning of a new distribution agreement with HÖLZEL, a German distributor.

Under this agreement, HÖLZEL will promote and distribute CALIXAR’s high-quality membrane protein targets (for antibody development, drug discovery, and vaccine formulation) and customized reagents specifically designed for the extraction and/or stabilization of membrane proteins.


HÖLZEL was founded in 1993 by a biologist, Veit Hölzel in Cologne (Germany). This family business proposes a wide range (about 6 million) of high-quality biological products for laboratories and research. They value efficacity, reliability, flexibility and fair prices for their work and relation with customers.

Share on Facebook
Share on Twitter
Share on LinkedIn